Efficacy and Safety of Intramuscular Administration of Allogeneic Adipose Tissue Derived and Expanded Mesenchymal Stromal Cells in Diabetic Patients with Critical Limb Ischemia with No Possibility of Revascularization: Study Protocol for a Randomized Controlled Double-Blind Phase II Clinical Trial (the NOMA Trial)

By
Justin.choi
-
0
44
The authors evaluated the feasibility, safety, and efficacy of cell therapy based on mesenchymal stromal cells derived from adipose tissue intramuscular administration to patients with type 2 diabetes mellitus with critical limb ischemia and without possibility of revascularization.
[Trials]
Full Article